{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:43:55Z","timestamp":1770504235969,"version":"3.49.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,3,1]],"date-time":"1987-03-01T00:00:00Z","timestamp":541555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1987,3]]},"DOI":"10.1007\/bf00274217","type":"journal-article","created":{"date-parts":[[2004,10,2]],"date-time":"2004-10-02T23:12:48Z","timestamp":1096758768000},"page":"132-143","source":"Crossref","is-referenced-by-count":157,"title":["Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus"],"prefix":"10.1007","volume":"30","author":[{"given":"D. W.","family":"Drell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Notkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"35","volume-title":"Immunology in diabetes","author":"AA Rossini","year":"1984","unstructured":"Rossini AA, Mordes JP, Like AA (1984) Animal models of insulin-dependent diabetes mellitus. In: Immunology in diabetes. Andreani D, DiMario U, Federlin KF, Heding LG (eds) Kimpton, London, pp 35?44"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00283644","volume":"26","author":"GF Bottazzo","year":"1984","unstructured":"Bottazzo GF (1984) ?-cell damage in diabetic insulitis: are we approaching a solution? Diabetologia 26: 241?249","journal-title":"Diabetologia"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","volume":"314","author":"GS Eisenbarth","year":"1986","unstructured":"Eisenbarth GS (1986) Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360?1368","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4612-5250-4_34","volume-title":"Concepts in viral pathogenesis","author":"AL Notkins","year":"1984","unstructured":"Notkins AL, Yoon JW (1984) Virus-induced diabetes mellitus. In: Concepts in viral pathogenesis. Notkins AL, Oldstone MBA (eds) Springer, New York, pp 241?247"},{"key":"CR5","first-page":"71","volume-title":"Immunology in diabetes","author":"A Toniolo","year":"1984","unstructured":"Toniolo A, Onodera T (1984) Viruses and diabetes. In: Immunology in diabetes. Andreani D, DiMario U, Federlin KF, Heding LG (eds) Kimpton, London, pp 71?93"},{"key":"CR6","first-page":"95","volume-title":"Immunology in diabetes","author":"GF Bottazzo","year":"1984","unstructured":"Bottazzo GF, Pozzilli P, Mirakian R, Dean BM, Doniach D (1984) Early immunological events in diabetes. In: Immunology in diabetes. Andreani D, DiMario U, Federlin KF, Heding LG (eds) Kimpton, London, pp 95?104"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.iy.03.040185.001445","volume":"3","author":"AA Rossini","year":"1985","unstructured":"Rossini AA, Mordes JP, Like AA (1985) Immunology of insulin-dependent diabetes mellitus. Ann Rev Immunol 3: 289?320","journal-title":"Ann Rev Immunol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4684-4559-6_12","volume-title":"Immunology of clinical and experimental diabetes","author":"J Nerup","year":"1984","unstructured":"Nerup J, Lernmark A, Scott J (1984) Autoimmunity. In: Immunology of clinical and experimental diabetes. Gupta S (ed) Plenum, New York, pp 351?367"},{"key":"CR9","first-page":"249","volume-title":"Autoimmune aspects of endocrine disorders","author":"WJ Irvine","year":"1980","unstructured":"Irvine WJ (1980) Autoimmunity and diabetes. In: Autoimmune aspects of endocrine disorders. Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Academic Press, London, pp 249?274"},{"key":"CR10","first-page":"287","volume-title":"Autoimmunity and endocrine disease","author":"BS Handwerger","year":"1985","unstructured":"Handwerger BS (1985) The immunology of diabetes mellitus. In: Autoimmunity and endocrine disease. Volpe R (ed) Marcel Dekker, New York, pp 287?344"},{"key":"CR11","first-page":"47","volume":"2","author":"MJ Dobersen","year":"1985","unstructured":"Dobersen MJ (1985) Humoral autoimmune aspects of insulin-dependent (Type 1) diabetes mellitus. Concepts Immunopathol 2: 47?64","journal-title":"Concepts Immunopathol"},{"key":"CR12","first-page":"167","volume-title":"Autoimmune endocrine disease","author":"GK Papadopoulos","year":"1983","unstructured":"Papadopoulos GK, Lernmark A (1983) The spectrum of islet cell antibodies. In: Autoimmune endocrine disease. Davies TF (ed) Wiley, New York, pp 167?180"},{"key":"CR13","first-page":"105","volume-title":"Immunology in diabetes","author":"KC Herold","year":"1984","unstructured":"Herold KC, Huen AH-J, Rubenstein AH, Lernmark A (1984) Humoral abnormalities in type 1 (insulin-dependent) diabetes mellitus. In: Immunology in diabetes. Andreani D, DiMario U, Federlin KF, Heding LG (eds) Kimpton, London, pp 105?120"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198012253032601","volume":"303","author":"MJ Dobersen","year":"1980","unstructured":"Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL (1980) Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303: 1493?1498","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI110048","volume":"67","author":"GS Eisenbarth","year":"1981","unstructured":"Eisenbarth GS, Morris MA, Scearce RM (1981) Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J Clin Invest 67: 403?408","journal-title":"J Clin Invest"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0300-595X(82)80022-4","volume":"11","author":"CH Brogren","year":"1982","unstructured":"Brogren CH, Lernmark A (1982) Islet cell antibodies in diabetes. Clin Endocrinol Metab 11: 409?430","journal-title":"Clin Endocrinol Metab"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diab.32.5.460","volume":"32","author":"AH-J Huen","year":"1983","unstructured":"Huen AH-J, Haneda M, Freedman Z, Lernmark A, Rubenstein AH (1983) Quantitative determination of islet cell surface antibodies using 125I-protein A. Diabetes 32: 460?465","journal-title":"Diabetes"},{"key":"CR18","first-page":"291","volume-title":"Autoimmune aspects of endocrine disease","author":"H Kolb","year":"1980","unstructured":"Kolb H, Stroheker M, Biener J, Gruneklee D, Muntefering H, Gries FA (1980) Analysis of the persistence of islet cell antibodies and islet cell type-specific antibodies in type 1 diabetic children. In: Autoimmune aspects of endocrine disease. Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Academic Press, London, pp 291?294"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(84)91841-5","volume":"1","author":"W Riley","year":"1984","unstructured":"Riley W, Maclaren N (1984) Islet cell antibodies are seldom transient. Lancet 1: 1351?1352","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/diab.26.2.138","volume":"26","author":"WJ Irvine","year":"1977","unstructured":"Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138?147","journal-title":"Diabetes"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3476(82)80227-8","volume":"100","author":"GM Bright","year":"1982","unstructured":"Bright GM, Blizzard RM, Kaiser DL, Clarke WL (1982) Organ-specific autoantibodies in children with common endocrine diseases. J Pediatr 100: 8?14","journal-title":"J Pediatr"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diab.26.10.909","volume":"26","author":"GF Prete Del","year":"1977","unstructured":"Del Prete GF, Betterle C, Padovan D, Erle G, Toffolo A, Bersahi G (1977) Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus. Diabetes 26: 909?915","journal-title":"Diabetes"},{"key":"CR23","first-page":"125","volume":"39","author":"B Rodger","year":"1980","unstructured":"Rodger B, Whittmgham S, Martin FIR, Hawkins BR, Dawkins RL, Welborn TA (1980) A population survey of pancreatic islet cell antibodies. Clin Exp Immunol 39: 125?129","journal-title":"Clin Exp Immunol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(76)92033-X","volume":"2","author":"R Lendram","year":"1976","unstructured":"Lendram R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet-cell antibodies in diabetes mellitus. Lancet 2: 1273?1276","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(81)92795-1","volume":"2","author":"AN Gorsuch","year":"1981","unstructured":"Gorsuch AN, Lister J, Dean BM, Spencer KN, McNally JM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet 2: 1363?1365","journal-title":"Lancet"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198302103080607","volume":"308","author":"S Srikanta","year":"1983","unstructured":"Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS (1983) Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for type 1 diabetes mellitus. N Engl J Med 308: 322?325","journal-title":"N Engl J Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00273904","volume":"27","author":"A Mustonen","year":"1984","unstructured":"Mustonen A, Knip M, Huttunen N-P, Puukka R, Kaar M-L, Akerblom HK (1984) Evidence of delayed ?-cell destraction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies. Diabetologia 27: 421?426","journal-title":"Diabetologia"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.1985.03360110059024","volume":"254","author":"F Ginsberg-Fellner","year":"1985","unstructured":"Ginsberg-Fellner F, Witt ME, Franklin BH, Yagihashi S, Toguchi Y, Dobersen MJ, Rubenstein P, Notkins AL (1985) Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus. J Am Med Assoc 254: 1469?1472","journal-title":"J Am Med Assoc"},{"key":"CR29","first-page":"1","volume-title":"Immunology of diabetes","author":"WJ Irvine","year":"1980","unstructured":"Irvine WJ (1980) Immunological aspects of diabetes mellitus: a review. (1980) In: Immunology of diabetes. Irvine WJ (ed) Teviot, Edinburgh, pp 1?53"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(81)90420-4","volume":"70","author":"J Nerup","year":"1981","unstructured":"Nerup J, Lernmark A (1981) Autoimmunity in insulin-dependent diabetes mellitus. Am J Med 70: 135?141","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"CR31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.8.1.S34","volume":"8","author":"NK Maclaren","year":"1985","unstructured":"Maclaren NK, Riley WJ (1985) Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 8 [Suppl 1]: 34?38","journal-title":"Diabetes Care"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.2.6131.165","volume":"2","author":"GF Bottazzo","year":"1978","unstructured":"Bottazzo GF, Mann JI, Thorogood M, Baum JD, Doniach D (1978) Autoimmunity in juvenile diabetics and their families. Br Med J 2: 165?168","journal-title":"Br Med J"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF00291971","volume":"28","author":"K Notsu","year":"1985","unstructured":"Notsu K, Oka N, Note S, Nabeya N, Kuno S, Sakurami T (1985) Islet cell antibodies in the Japanese population and subjects with Type-1 (insulin-dependent) diabetes. Diabetologia 28: 660?662","journal-title":"Diabetologia"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diab.34.9.855","volume":"34","author":"Y Toguchi","year":"1985","unstructured":"Toguchi Y, Ginsberg-Fellner F, Rubenstein P (1985) Cytotoxic islet cell surface antibodies (ICSA) in patients with Type 1 diabetes and their first-degree relatives. Diabetes 34: 855?860","journal-title":"Diabetes"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/298167a0","volume":"298","author":"S Baekkeskov","year":"1982","unstructured":"Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet-cell proteins. Nature 298: 167?169","journal-title":"Nature"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.6362005","volume":"222","author":"JP Palmer","year":"1983","unstructured":"Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337?1339","journal-title":"Science"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/diab.35.5.620","volume":"35","author":"J Karjalainen","year":"1986","unstructured":"Karjalainen J, Knip M, Mustonen A, Ilonen J, Akerblom HK (1986) Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 35: 620?622","journal-title":"Diabetes"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(85)92086-0","volume":"1","author":"T Wilkin","year":"1985","unstructured":"Wilkin T, Armitage M, Casey C, Pyke DA, Hoskins PJ, Rodier M, Diaz JL, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1: 480?482","journal-title":"Lancet"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diab.34.9.926","volume":"34","author":"SA Arslanian","year":"1985","unstructured":"Arslanian SA, Becker DJ, Rabin B, Atchison R, Eberhardt M, Cavender D, Dorman J, Drash AL (1985) Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34: 926?930","journal-title":"Diabetes"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.35.6.634","volume":"35","author":"RC McEvoy","year":"1986","unstructured":"McEvoy RC, Witt ME, Ginsberg-Fellner F, Rubinstein P (1986) Anti-insulin antibodies in children with type 1 diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement. Diabetes 35: 634?641","journal-title":"Diabetes"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(75)91945-5","volume":"1","author":"NK Maclaren","year":"1975","unstructured":"Maclaren NK, Huang S-W, Fogh J (1975) Antibody to cultured human insulinoma cells in insulin-dependent diabetes. Lancet 1: 997?1000","journal-title":"Lancet"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/303817a0","volume":"303","author":"R Maron","year":"1983","unstructured":"Maron R, Elias D, de Jongh BM, Braining GJ, van Rood JJ, Schechter Y, Cohen IR (1983) Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes. Nature 303: 817?818","journal-title":"Nature"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJM198406073102320","volume":"310","author":"K Schopfer","year":"1984","unstructured":"Schopfer K, Matter L, Tenschert R, Bauer S, Zuppinger K (1984) Anti-glucagon-cell and anti-adrenal-medullary-cell antibodies in islet-cell-autoantibody-positive diabetic children. N Engl J Med 310: 1536?1537","journal-title":"N Engl J Med"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(76)90538-9","volume":"2","author":"GF Bottazzo","year":"1976","unstructured":"Bottazzo GF, Lendram R (1976) Separate autoantibodies to human pancreatic glucagon and somatostatin cells. Lancet 2: 873?876","journal-title":"Lancet"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/diab.30.1.26","volume":"30","author":"S Serjeantson","year":"1981","unstructured":"Serjeantson S, Theophilus J, Zimmet P, Court J, Crossley JR, Elliott RB (1981) Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus. Diabetes 30: 26?29","journal-title":"Diabetes"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00922759","volume":"1","author":"S Srikanta","year":"1981","unstructured":"Srikanta S, Malaviya AN, Mehra NK, Vaidya MC, Geevarghese PJ, Ahuja MMS (1981) Autoimmunity in type 1 (insulin-dependent) diabetes mellitus in North India. J Clin Immunol 1: 169?173","journal-title":"J Clin Immunol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1507\/endocrj1954.26.599","volume":"26","author":"K Nagaoka","year":"1979","unstructured":"Nagaoka K, Sakurami T, Nabeya N, Imura H, Kuno S (1979) Antimicrosomal antibodies, gastric parietal cell antibodies and antinuclear factors in insulin-dependent diabetes mellitus. Endocrinol Jpn 26: 599?603","journal-title":"Endocrinol Jpn"},{"key":"CR48","first-page":"2795","volume":"10","author":"H Dorchy","year":"1981","unstructured":"Dorchy H, Lemiere B, Toussaint D, Gausset P (1981) Anticorps anticellules des ilots de Langerhans et specifiques d'organes chez les jeunes diabetiques. Nouv Presse Med 10: 2795?2798","journal-title":"Nouv Presse Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3476(70)80342-0","volume":"77","author":"E Goldstein","year":"1970","unstructured":"Goldstein E, Drash A, Gibbs J, Blizzard RM (1970) Diabetes mellitus: the incidence of circulating antibodies against thyroid, gastric, and adrenal tissue. J Pediatr 77: 304?306","journal-title":"J Pediatr"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/acta.0.0720279","volume":"72","author":"J Nerup","year":"1973","unstructured":"Nerup J, Binder C (1973) Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. Acta Endocrinol 72: 279?286","journal-title":"Acta Endocrinol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1651-2227.1982.tb09403.x","volume":"71","author":"J Kokkonen","year":"1982","unstructured":"Kokkonen J, Kiuttu J, Mustonen A, Rasanen O (1982) Organ-specific antibodies in healthy and diabetic children and young adults. Acta Paediatr Scand 71: 223?226","journal-title":"Acta Paediatr Scand"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00262215","volume":"26","author":"C Betterle","year":"1984","unstructured":"Betterle C, Zanette F, Pedini B, Presotto F, Rapp LB, Monciotti CM, Rigon F (1984) Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26: 431?436","journal-title":"Diabetologia"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(70)92531-6","volume":"2","author":"WJ Irvine","year":"1970","unstructured":"Irvine WJ, Scarth L, Clarke BF, Cullen R, Duncan LJP (1970) Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet 2: 163?168","journal-title":"Lancet"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2337\/diab.29.8.589","volume":"29","author":"M Neufeld","year":"1980","unstructured":"Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, Rosenbloom AL (1980) Islet cell and other organ-specific antibodies in US Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 29: 589?592","journal-title":"Diabetes"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(71)91212-8","volume":"1","author":"S Whittingham","year":"1971","unstructured":"Whittingham S, Mathews JD, Mackay IR, Stocks AE, Ungar B, Martin FIR (1971) Diabetes mellitus, autoimmunity and ageing. Lancet 1: 763?767","journal-title":"Lancet"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jcem-58-6-1166","volume":"58","author":"CH Ketchum","year":"1984","unstructured":"Ketchum CH, Riley WJ, Maclaren NK (1984) Adrenal dysfunction in asymptomatic patients with adrenocortical autoantibodies. J Clin Endocrinol Metab 58: 1166?1170","journal-title":"J Clin Endocrinol Metab"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(68)90462-5","volume":"2","author":"B Ungar","year":"1968","unstructured":"Ungar B, Stocks AE, Martin FIR, Whittingham S, Mackay IR (1968) Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anaemia in diabetes mellitus. Lancet 2: 415?418","journal-title":"Lancet"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diab.17.3.136","volume":"17","author":"S Simkins","year":"1968","unstructured":"Simkins S (1968) Antithyroglobulin antibodies in diabetes mellitus. Diabetes 17: 136?140","journal-title":"Diabetes"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2362.1984.tb01216.x","volume":"14","author":"H Bliddal","year":"1984","unstructured":"Bliddal H, Bech K, Johansen K, Nerup J (1984) Thyroid-stimulating immunoglobulins in insulin-dependent diabetes mellitus. Eur J Clin Invest 14: 474?478","journal-title":"Eur J Clin Invest"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(82)91809-8","volume":"1","author":"R Mirakian","year":"1982","unstructured":"Mirakian R, Bottazzo GF, Cudworth AG, Richardson CA, Doniach D (1982) Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus. Lancet 1: 755?759","journal-title":"Lancet"},{"key":"CR61","first-page":"111","volume":"3","author":"M Sugiura","year":"1986","unstructured":"Sugiura M, Hashimoto A, Shizawa M, Tsukada M, Maruyama S, Ishido T, Kasahara T, Hirata Y (1986) Heterogeneity of anterior pituitary cell antibodies detected in insulin-dependent diabetes mellitus and adrenocorticotropic hormone deficiency. Diabetes Res 3: 111?114","journal-title":"Diabetes Res"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00273905","volume":"27","author":"B Rousset","year":"1984","unstructured":"Rousset B, Vialettes B, Bernier-Valentin F, Vaque P, Mornex R (1984) Anti-tubulin antibodies in recent onset type 1 (insulin-dependent) diabetes mellitus: comparison with islet cell antibodies. Diabetologia 27: 427?432","journal-title":"Diabetologia"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00313028309083511","volume":"15","author":"MA Menser","year":"1983","unstructured":"Menser MA, Hudson JR (1983) Pancreatic islet and other auto-antibodies in juvenile and adult onset diabetics in Australia. Pathology 15: 309?313","journal-title":"Pathology"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1507\/endocrj1954.30.469","volume":"30","author":"K Notsu","year":"1983","unstructured":"Notsu K, Note S, Nabeya N, Kuno S, Sakurami T (1983) Antinuclear antibodies in childhood diabetics. Endocrinol Jpn 30: 469?473","journal-title":"Endocrinol Jpn"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/diab.30.10.873","volume":"30","author":"S-W Huang","year":"1981","unstructured":"Huang S-W, Haedt LH, Rich S, Barbosa J (1981) Prevalence of antibodies to nucleic acids in insulin-dependent diabetics and their relatives. Diabetes 30: 873?874","journal-title":"Diabetes"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(85)91843-4","volume":"1","author":"JE Banatvala","year":"1985","unstructured":"Banatvala JE, Schernthaner G, Schober E, De Silva LM, Bryant J, Borkenstein M, Brown D, Menser MA, Silink M (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1: 1409?1412","journal-title":"Lancet"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jmv.1890170303","volume":"17","author":"G Frisk","year":"1985","unstructured":"Frisk G, Fohlman J, Kobbah M, Ewald U, Tuvemo T, Diderholm H, Friman G (1985) High frequency of Coxsackie-B-virus-specific IgM in children developing type 1 diabetes during a period of high diabetes morbidity. J Med Virol 17: 219?227","journal-title":"J Med Virol"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/BF01939684","volume":"34","author":"EN Wardle","year":"1978","unstructured":"Wardle EN (1978) An antibody to low density lipoprotein in diabetics. Experientia 34: 886?887","journal-title":"Experientia"},{"key":"CR69","first-page":"17","volume":"11","author":"U Mario Di","year":"1983","unstructured":"Di Mario U, Irvine WJ, Guy K, Borsey DQ, Iavicoli M, Ventriglia L (1983) Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment. J Clin Lab Immunol 11: 17?20","journal-title":"J Clin Lab Immunol"},{"key":"CR70","first-page":"313","volume-title":"Autoimmune aspects of endocrine disease","author":"H Ludwig","year":"1980","unstructured":"Ludwig H, Schernthaner G, Tappeiner G, Mayr WR, Freyler H (1980) Circulating immune complexes in insulin-dependent diabetes: analysis of incidence of islet cell antibodies, insulin antibodies, HLA antigens, duration of disease and stages of diabetic retinopathy. In: Autoimmune aspects of endocrine disease. Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Acad Press, London, pp 313?318"},{"key":"CR71","first-page":"96","volume":"40","author":"G Delespesse","year":"1980","unstructured":"Delespesse G, Gansset P, Sarfati M, Dubi-Rucquoy M, Debisschop M-J, van Haelst L (1980) Circulating immune complexes in old people and in diabetics: correlation with autoantibodies. Clin Exp Immunol 40: 96?102","journal-title":"Clin Exp Immunol"},{"key":"CR72","first-page":"64","volume":"96","author":"ZR Freedman","year":"1976","unstructured":"Freedman ZR, Feek CM, Irvine WJ, Lernmark A, Rubenstein AH, Steiner DF, Huen A (1976) Islet cell cytoplasmic and cell surface antibodies in diabetes mellitus. Trans Assn Amer Phys 96: 64?76","journal-title":"Trans Assn Amer Phys"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(79)92477-2","volume":"2","author":"MJ Dobersen","year":"1979","unstructured":"Dobersen MJ, Bell AM, Jenson AB, Notkins AL, Ginsberg-Fellner F (1979) Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen. Lancet 2: 1078","journal-title":"Lancet"},{"key":"CR74","first-page":"727","volume":"21","author":"S Assa","year":"1985","unstructured":"Assa S, Karp M, Erster B, Laron Z (1985) Cytoplasmic islet cell antibodies in type 1 diabetics in Israel and their first-degree relatives. Isr J Med Sci 21: 727?730","journal-title":"Isr J Med Sci"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF00703129","volume":"28","author":"B Marner","year":"1985","unstructured":"Marner B, Agner T, Binder C, Lernmark A, Nerup J, Mandrup-Poulsen T, Walldorff S (1985) Increased reduction in fasting C-peptide is associated with islet cell antibodies in type-1 (insulin-dependent) diabetic patients. Diabetologia 28: 875?880","journal-title":"Diabetologia"},{"key":"CR76","first-page":"9","volume":"11","author":"DQ Borsey","year":"1983","unstructured":"Borsey DQ, Di Mario U, Irvine WJ, Gray RS, Guy K, Weston J, Peutherer J, Duncari LJP (1983) Humoral immunity in type 1 diabetes mellitus: a prospective study. J Clin Lab Immunol 11: 9?15","journal-title":"J Clin Lab Immunol"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"W Gepts","year":"1965","unstructured":"Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619?633","journal-title":"Diabetes"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/BF00262221","volume":"26","author":"AK Foulis","year":"1984","unstructured":"Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis, and associated changes in the endocrine acinar tissue. Diabetologia 26: 456?461","journal-title":"Diabetologia"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00275671","volume":"27","author":"M Rodier","year":"1984","unstructured":"Rodier M, Andary M, Richard JL, Mirouze J, Clot J (1984) Peripheral blood T-cell subsets studied by monoclonal antibodies in type 1 (insulin-dependent) diabetes: effect of blood glucose control. Diabetologia 27: 136?138","journal-title":"Diabetologia"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00275660","volume":"27","author":"KC Herold","year":"1984","unstructured":"Herold KC, Huen A, Gould L, Traisman H, Rubenstein AH (1984) Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia 27: 102?105","journal-title":"Diabetologia"},{"key":"CR81","first-page":"296","volume":"47","author":"F Mascart-Lemone","year":"1982","unstructured":"Mascart-Lemone F, Delespesse G, Dorchy H, Lemiere B, Servais G (1982) Characterization of immunoregulatory Tlymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Clin Exp Immunol 47: 296?300","journal-title":"Clin Exp Immunol"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00262214","volume":"26","author":"A Galluzzo","year":"1984","unstructured":"Galluzzo A, Giordano C, Rubino G, Bompiani GD (1984) Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 426?430","journal-title":"Diabetologia"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00279938","volume":"25","author":"K Buschard","year":"1983","unstructured":"Buschard K, Ropke C, Madsbad S, Mehlsen J, Rygaard J (1983) Tlymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia 25: 247?251","journal-title":"Diabetologia"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4049\/jimmunol.129.4.1426","volume":"129","author":"M Horita","year":"1982","unstructured":"Horita M, Suzuki H, Onodera T, Ginsberg-Fellner F, Fauci AS, Notkins AL (1982) Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. J Immunol 129: 1426?1429","journal-title":"J Immunol"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2337\/diab.33.4.319","volume":"33","author":"AR Hayward","year":"1984","unstructured":"Hayward AR, Herberger M (1984) Culture and phenotype of activated T-cells from patients with type-1 diabetes mellitus. Diabetes 33: 319?323","journal-title":"Diabetes"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM198204013061305","volume":"306","author":"RA Jackson","year":"1982","unstructured":"Jackson RA, Morris MA, Haynes BF, Eisenbarth GS (1982) Increased circulating la-antigen-bearing T cells in type 1 diabetes mellitus. N Engl J Med 306: 785?788","journal-title":"N Engl J Med"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF00275661","volume":"27","author":"J Ilonen","year":"1984","unstructured":"Ilonen J, Surcel H-M, Mustonen A, Kaar M-L, Akerblom HK (1984) Lymphocyte subpopulations at the onset of type-1 (insulin-dependent) diabetes. Diabetologia 27: 106?108","journal-title":"Diabetologia"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-2478(84)90056-7","volume":"8","author":"KG Chandy","year":"1984","unstructured":"Chandy KG, Charles MA, Buckingham B, Waldeck N, Kershnar A, Gupta S (1984) Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus. Immunol Lett 8: 89?91","journal-title":"Immunol Lett"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0140-6736(84)91994-9","volume":"2","author":"L Alviggi","year":"1984","unstructured":"Alviggi L, Hoskins PJ, Pyke DA, Johnston C, Tee DEH, Leslie RDG, Vergani D (1984) Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet 2: 4?6","journal-title":"Lancet"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2337\/diab.33.6.552","volume":"33","author":"KS Zier","year":"1984","unstructured":"Zier KS, Leo MM, Spielman RS, Baker L (1984) Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes 33: 552?555","journal-title":"Diabetes"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1398-9995.1973.tb01443.x","volume":"28","author":"J Nerup","year":"1973","unstructured":"Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE (1973) Antipancreatic, cellular hypersensitivity in diabetes mellitus: antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta Allergol 28: 223?230","journal-title":"Acta Allergol"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diab.23.8.693","volume":"23","author":"AC MacCuish","year":"1974","unstructured":"MacCuish AC, Jordan J, Campbell CJ, Duncan LJP, Irvine WJ (1974) Cell-mediated immunity to human pancreas in diabetes mellitus. Diabetes 23: 693?697","journal-title":"Diabetes"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1210\/jcem-57-4-700","volume":"57","author":"D Topliss","year":"1983","unstructured":"Topliss D, How J, Lewis M, Row V, Volpe R (1983) Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endocrinol Metab 57: 700?705","journal-title":"J Clin Endocrinol Metab"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1507\/endocrj1954.32.497","volume":"32","author":"Y Mori","year":"1985","unstructured":"Mori Y, Matsuda I, Tsuruoka A, Sasaki A, Utsunomiya K Ishii K, Yamada H, Tanese T, Ishikawa H, Suko M, Shida T, Ikeda Y (1985) Cellular hypersensitivity to human pancreatic B-cell clone in diabetes mellitus and its relationship to the presence of islet cell antibodies. Endocrinol Jpn 32: 497?504","journal-title":"Endocrinol Jpn"},{"key":"CR95","first-page":"59","volume":"11","author":"S Gupta","year":"1983","unstructured":"Gupta S, Fikrig S, Orti E (1983) Autologous mixed lymphocyte reaction in man VI. Deficiency of autologous mixed lymphocyte reaction in type 1 (insulin-dependent) diabetes mellitus. J Clin Lab Immunol 11: 59?62","journal-title":"J Clin Lab Immunol"},{"key":"CR96","first-page":"461","volume":"18","author":"G Delespesse","year":"1974","unstructured":"Delespesse G, Duchateau J, Bastenie PA, Lauvaux JP, Collet H, Govaerts A (1974) Cell-mediated immunity in diabetes mellitus. Clin Exp Immunol 18: 461?467","journal-title":"Clin Exp Immunol"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/diab.24.1.36","volume":"24","author":"AC MacCuish","year":"1975","unstructured":"MacCuish AC, Jordan J, Campbell CJ, Duncan LJP, Irvine WJ (1975) Cell-mediated immunity in diabetes mellitus. Lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetics. Diabetes 24: 36?43","journal-title":"Diabetes"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4049\/jimmunol.131.2.701","volume":"131","author":"L Nell","year":"1983","unstructured":"Nell L, Thomas JW (1983) The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics. J Immunol 131: 701?705","journal-title":"J Immunol"},{"key":"CR99","first-page":"175","volume":"2","author":"AB Kurtz","year":"1985","unstructured":"Kurtz AB, Di Silvio L, Lydyard P (1985) Lymphocyte proliferation as a test of the immune response to insulin in diabetics. Diabetes Res 2: 175?178","journal-title":"Diabetes Res"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000441-197206000-00005","volume":"263","author":"JD Bagdade","year":"1972","unstructured":"Bagdade JD, Nielson KL, Bulger RJ (1972) Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 263: 451?456","journal-title":"Am J Med Sci"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/diab.23.3.218","volume":"23","author":"A Berken","year":"1974","unstructured":"Berken A, Sherman AA (1974) Reticuloendothelial system phagocytosis in diabetes mellitus. Diabetes 23: 218?220","journal-title":"Diabetes"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(79)91436-3","volume":"2","author":"P Pozzilli","year":"1979","unstructured":"Pozzilli P, Gorsuch A, Sensi M., Bottazzo GF, Cudworth AG (1979) Evidence for raised K-cell levels in type-1 diabetes. Lancet 2: 173?175","journal-title":"Lancet"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4049\/jimmunol.130.3.1189","volume":"130","author":"MA Charles","year":"1983","unstructured":"Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M (1983) Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 130: 1189?1194","journal-title":"J Immunol"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.769160","volume":"192","author":"S-W Huang","year":"1976","unstructured":"Huang S-W, Maclaren NK (1976) Insulin-dependent diabetes: a disease of autoaggression. Science 192: 64?66","journal-title":"Science"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00423148","volume":"16","author":"JL Selam","year":"1979","unstructured":"Selam JL, Clot J, Andary M, Mirouze J (1979) Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes: correction of abnormalities by adequate blood glucose control. Diabetologia 16: 35?40","journal-title":"Diabetologia"},{"key":"CR106","first-page":"329","volume-title":"Autoimmune aspects of endocrine disease","author":"E Cacciari","year":"1980","unstructured":"Cacciari E, Masi M, Franceschi C, Cicognani A, Pirazzoli P, Licastro F, Fantini MP, Chiricolo M, Tassinari D (1980) Immunological abnormalities in juvenile onset diabetes. In: Autoimmune aspects of endocrine disease. Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Acad Press, London, pp 329?332"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/IAI.21.2.425-429.1978","volume":"21","author":"JF Plouffe","year":"1978","unstructured":"Plouffe JF, Silva J Jr, Fekety R, Alien JL (1978) Cell-mediated immunity in diabetes mellitus. Infect Immun 21: 425?429","journal-title":"Infect Immun"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.127.5.2051","volume":"127","author":"MM Lederman","year":"1981","unstructured":"Lederman MM, Ellner JJ, Rodman HM (1981) Defective suppressor cell generation in juvenile onset diabetes. J Immunol 127: 2051?2055","journal-title":"J Immunol"},{"key":"CR109","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diab.23.8.708","volume":"23","author":"AC MacCuish","year":"1974","unstructured":"MacCuish AC, Urbaniak SJ, Campbell CJ, Duncan LJP, Irvine WJ (1974) Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes 23: 708?712","journal-title":"Diabetes"},{"key":"CR110","first-page":"175","volume":"99","author":"RS Fairchild","year":"1982","unstructured":"Fairchild RS, Kyner JL, Abdou NI (1982) Specific immunoregulation abnormality in insulin-dependent diabetes mellitus. J Lab Clin Med 99: 175?186","journal-title":"J Lab Clin Med"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0198-8859(83)90004-6","volume":"7","author":"MA Jaworski","year":"1983","unstructured":"Jaworski MA, Colle E, Guttmann RD (1983) Abnormal immunoregulation in patients with insulin dependent diabetes mellitus and their healthy first degree relatives. Hum Immunol 7: 25?34","journal-title":"Hum Immunol"},{"key":"CR112","first-page":"65","volume":"13","author":"K Buschard","year":"1984","unstructured":"Buschard K, Madsbad S (1984) A longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin dependent) diabetes mellitus. J Clin Lab Immunol 13: 65?70","journal-title":"J Clin Lab Immunol"},{"key":"CR113","first-page":"25","volume":"41","author":"K Buschard","year":"1980","unstructured":"Buschard K, Madsbad S, Rygaard J (1980) Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin Exp Immunol 41: 25?32","journal-title":"Clin Exp Immunol"},{"key":"CR114","first-page":"485","volume":"22","author":"CC Rerup","year":"1970","unstructured":"Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485?518","journal-title":"Pharmacol Rev"},{"key":"CR115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-187820-7.50021-8","volume-title":"The islets of Langerhans","author":"SJ Cooperstein","year":"1981","unstructured":"Cooperstein SJ, Watkins D (1981) Action of toxic drugs on islet cells. In: The islets of Langerhans. Cooperstein SJ, Watkins D (eds) Academic Press, New York, pp 387?425"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4684-4559-6_4","volume-title":"Immunology of clinical and experimental diabetes","author":"A Naji","year":"1984","unstructured":"Naji A, Barker CF (1984) Animal models of human type 1 diabetes. In: Immunology of clinical and experimental diabetes. Gupta S (ed) Plenum, New York, pp 91?112"},{"key":"CR117","first-page":"281","volume":"15","author":"C Boitard","year":"1986","unstructured":"Boitard C, Debray-Sachs M, Bach JF (1986) Autoimmune disorders in diabetes. Adv Nephrol 15: 281?305","journal-title":"Adv Nephrol"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0008-8749(81)90314-2","volume":"62","author":"KL Pasko","year":"1981","unstructured":"Pasko KL, Salvin SB, Winkelstein A (1981) Mechanisms in the in vivo release of lymphokines. V. Responses in alloxan-treated and genetically diabetic mice. Cell Immunol 62: 205?219","journal-title":"Cell Immunol"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0028-1093396","volume":"10","author":"K Pavelic","year":"1978","unstructured":"Pavelic K, Slijepcevic M, Pavelic J (1978) Recovery of immune system in diabetic mice after treatment with insulin. Horm Metab Res 10: 381?386","journal-title":"Horm Metab Res"},{"key":"CR120","first-page":"319","volume":"19","author":"W Ptak","year":"1975","unstructured":"Ptak W, Czarnik Z, Hanczakowska M (1975) Contact sensitivity in alloxan-diabetic mice. Clin Exp Immunol 19: 319?325","journal-title":"Clin Exp Immunol"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2337\/diacare.20.10.825","volume":"29","author":"MD Roth","year":"1980","unstructured":"Roth MD, Barg M, Michalski R, Arquilla ER (1980) Cell-mediated immunity in chronically diabetic mice. Diabetes 29: 825?829","journal-title":"Diabetes"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1172\/JCI108287","volume":"57","author":"AAF Mahmoud","year":"1976","unstructured":"Mahmoud AAF, Rodman HM, Mandel MA, Warren KS (1976) Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity, and allograft rejection. J Clin Invest 57: 362?367","journal-title":"J Clin Invest"},{"key":"CR123","first-page":"140","volume":"29","author":"W Ptak","year":"1977","unstructured":"Ptak W, Hanczakowska M, Rozycka R, Rozycka D (1977) Impaired antibody responses in alloxan diabetic mice. Clin Exp Immun 29: 140?146","journal-title":"Clin Exp Immun"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF00265026","volume":"28","author":"GN Gaulton","year":"1985","unstructured":"Gaulton GN, Schwartz JL, Eardley DD (1985) Assessment of the diabetogenic drags alloxan and streptozotocin as models for the study of immune defects in diabetic mice. Diabetologia 28: 769?775","journal-title":"Diabetologia"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.124.2.227","volume":"124","author":"RH Drachman","year":"1966","unstructured":"Drachman RH, Root RK, Wood WB Jr (1966) Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis. J Exp Med 124: 227?240","journal-title":"J Exp Med"},{"key":"CR126","first-page":"37","volume":"5","author":"DM Weir","year":"1981","unstructured":"Weir DM, Blackwell CC, McLean CA (1981) Impaired bacterial binding to peritoneal exudate cells from mice with alloxan induced diabetes. J Clin Lab Immunol 5: 37?40","journal-title":"J Clin Lab Immunol"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diab.25.7.614","volume":"25","author":"MG Pallavicini","year":"1976","unstructured":"Pallavicini MG, Nichols WK (1976) Inhibition of lymphocyte blastogenesis by factor(s) in alloxan-diabetic rat plasma. Diabetes 25: 614?622","journal-title":"Diabetes"},{"key":"CR128","first-page":"417","volume":"43","author":"DE Nevalainen","year":"1977","unstructured":"Nevalainen DE, Hoftiezer V (1977) The response of C3H mice to streptozotocin. I.Thymic depression and leukocyte toxicity. Am J Med Technol 43: 417?418","journal-title":"Am J Med Technol"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00423151","volume":"16","author":"WK Nichols","year":"1979","unstructured":"Nichols WK, Spellman JB, Vann LL, Daynes RA (1979) Immune responses of diabetic animals: direct immunosuppressant effects of streptozotocin in mice. Diabetologia 16: 51?57","journal-title":"Diabetologia"},{"key":"CR130","first-page":"627","volume":"46","author":"WK Nichols","year":"1981","unstructured":"Nichols WK, Vann LL, Spellman JB (1981) Streptozotocin effects on T lymphocytes and bone marrow cells. Clin Exp Immunol 46: 627?632","journal-title":"Clin Exp Immunol"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2337\/diab.29.7.516","volume":"29","author":"T Ishabashi","year":"1980","unstructured":"Ishabashi T, Kitahara Y, Harada Y, Harada S, Takamoto M, Ishibashi T (1980) Immunologic features of mice with streptozotocin-induced diabetes. Depression of their immune responses to sheep red blood cells. Diabetes 29: 516?523","journal-title":"Diabetes"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2337\/diacare.31.12.1098","volume":"31","author":"DS Chi","year":"1982","unstructured":"Chi DS, Berry DL, Dillon KA, Arbogast BW (1982) Inhibition of in vitro lymphocyte response by streptozotocin-induced diabetic rat serum: a function of very-low-density lipoproteins. Diabetes 31: 1098?1104","journal-title":"Diabetes"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/IAI.28.1.127-131.1980","volume":"28","author":"O Saiki","year":"1980","unstructured":"Saiki O, Negoro S, Tsuyuguchi I, Yamamura Y (1980) Depressed immunological defense mechanisms in mice with experimentally induced diabetes. Infect Immun 28: 127?131","journal-title":"Infect Immun"},{"key":"CR134","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-1229(84)90272-1","volume":"32","author":"BS Handwerger","year":"1984","unstructured":"Handwerger BS, Fernandes G, Riehm T, Sutherland DER, Brown DM (1984) Alterations in immunological function in streptozotocin-induced murine diabetes mellitus: correction by islet cell transplantation. Clin Immunol Immunopathol 32: 275?284","journal-title":"Clin Immunol Immunopathol"},{"key":"CR135","first-page":"590","volume":"43","author":"Y Kitahara","year":"1981","unstructured":"Kitahara Y, Ishibashi T, Harada Y, Takamoto M, Tanaka K (1981) Reduced resistance to Pseudomonas septicaemia in diabetic mice. Clin Exp Immunol 43: 590?598","journal-title":"Clin Exp Immunol"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/257597a0","volume":"257","author":"J Rhodes","year":"1975","unstructured":"Rhodes J (1975) Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides. Nature 257: 597?599","journal-title":"Nature"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01917915","volume":"35","author":"AO Lima","year":"1979","unstructured":"Lima AO, Queiroz M, Brascher HM, Vargens J (1979) Effect of insulin on immunological phagocytosis by macrophages. Experientia 35: 119?120","journal-title":"Experientia"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0609.1981.tb01636.x","volume":"26","author":"K Kragballe","year":"1981","unstructured":"Kragballe K, Beck-Nielsen H, Pedersen O, Ellegaard J, Sorensen NS (1981) Monocyte-mediated antibody-dependent cytoxicity. Modulation by glycolysis and insulin. Scan J Haematol 26: 137?144","journal-title":"Scan J Haematol"},{"key":"CR139","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/265632a0","volume":"265","author":"RS Bar","year":"1977","unstructured":"Bar RS, Kahn CR, Koren HS (1977) Insulin inhibition of antibody-dependent cytotoxicity and insulin receptors in macrophages. Nature 265: 632?634","journal-title":"Nature"},{"key":"CR140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.124.2.739","volume":"124","author":"EC Snow","year":"1980","unstructured":"Snow EC, Feldbush TL, Oaks JA (1980) The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro. J Immunol 124: 739?744","journal-title":"J Immunol"},{"key":"CR141","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4049\/jimmunol.126.4.1249","volume":"126","author":"J-I Kumagai","year":"1981","unstructured":"Kumagai J-I, Akiyama H, Iwashita S, Iida H, Yahara I (1981) In vitro regeneration of resting lymphocytes from stimulated lymphocytes and its inhibition by insulin. J Immunol 126: 1249?1254","journal-title":"J Immunol"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI110199","volume":"67","author":"JH Helderman","year":"1981","unstructured":"Helderman JH (1981) Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J Clin Invest 67: 1636?1642","journal-title":"J Clin Invest"},{"key":"CR143","first-page":"705","volume":"46","author":"F Diaz-Espada","year":"1982","unstructured":"Diaz-Espada F, Lopez-Alarcon L (1982) Mitogen-induced changes in glycolytic enzymes of mouse lymphocytes: influence of insulin on cell activation in vitro. Immunology 46: 705?712","journal-title":"Immunology"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4049\/jimmunol.128.4.1555","volume":"128","author":"TB Strom","year":"1982","unstructured":"Strom TB, Bangs JD (1982) Human serum-free mixed lymphocyte response: the stereospecific effect of insulin and its potentiation by transferrin. J Immunol 128: 1555?1559","journal-title":"J Immunol"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.126.1.161","volume":"126","author":"EC Snow","year":"1981","unstructured":"Snow EC, Feldbush TL, Oaks JA (1981) The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. J Immunol 126: 161?164","journal-title":"J Immunol"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1126\/science.163492","volume":"187","author":"TB Strom","year":"1975","unstructured":"Strom TB, Bear RA, Carpenter CB (1975) Insulin-induced augmentation of lymphocyte-mediated cytotoxicity. Science 187: 1206?1208","journal-title":"Science"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1172\/JCI108646","volume":"59","author":"JH Helderman","year":"1977","unstructured":"Helderman JH, Strom TB (1977) Emergence of insulin receptors upon alloimmune T cells in the rat. J Clin Invest 59: 338?344","journal-title":"J Clin Invest"},{"key":"CR148","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.4049\/jimmunol.136.11.3994","volume":"136","author":"P Hunt","year":"1986","unstructured":"Hunt P, Eardley DD (1986) Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses. J Immunol 136: 3994?3999","journal-title":"J Immunol"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.69.9.2604","volume":"69","author":"U Krug","year":"1972","unstructured":"Krug U, Krug F, Cuatrecasas P (1972) Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc Natl Acad Sci USA 69: 2604?2608","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR150","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1016\/S0021-9258(18)50304-5","volume":"254","author":"JH Helderman","year":"1979","unstructured":"Helderman JH, Strom TB (1979) Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. J Biol Chem 254: 7203?7207","journal-title":"J Biol Chem"},{"key":"CR151","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/newbio235174a0","volume":"235","author":"JW Hadden","year":"1972","unstructured":"Hadden JW, Hadden EM, Wilson EE, Good RA, Coffey RG (1972) Direct action of insulin on plasma membrane ATPase activity in human lymphocytes. Nature New Biol 235: 174?177","journal-title":"Nature New Biol"},{"key":"CR152","first-page":"889","volume":"66","author":"K Pavelic","year":"1981","unstructured":"Pavelic K, Vuk-Pavelic S (1981) Retarded growth of murine tumors in vivo by insulin- and glucagon-stimulated immunity and phagocytosis. J Nat Cancer Inst 66: 889?892","journal-title":"J Nat Cancer Inst"},{"key":"CR153","first-page":"83","volume":"53","author":"HL Bhakri","year":"1983","unstructured":"Bhakri HL, Jones H, Jones DA, Pettingale KW, Tee DEH (1983) T cell subpopulation dynamics following insulin-induced hypoglycemia in normal subjects. Clin Exp Immunol 53: 83?87","journal-title":"Clin Exp Immunol"},{"key":"CR154","doi-asserted-by":"crossref","unstructured":"Notkins AL, Prabhakar BS (1986) Monoclonal autoantibodies that react with multiple organs: basis for reactivity. In: Autoimmunity, experimental and clinical aspects. Schwarte RS, Rose NR (eds) Ann NY Acad Sci 475: 123?124","DOI":"10.1111\/j.1749-6632.1986.tb20862.x"},{"key":"CR155","first-page":"109","volume-title":"Autoimmunity and endocrine disease","author":"R Volpe","year":"1985","unstructured":"Volpe R (1985) Autoimmune thyroid disease. In: Autoimmunity and endocrine disease. Volpe R (ed) Marcel Dekker, New York, pp 109?285"},{"key":"CR156","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJM198410183111605","volume":"311","author":"Y Shoenfeld","year":"1984","unstructured":"Shoenfeld Y, Schwartz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311: 1019?1029","journal-title":"N Engl J Med"},{"key":"CR157","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4612-4958-0_23","volume-title":"Concepts in viral pathogenesis II","author":"MBA Oldstone","year":"1986","unstructured":"Oldstone MBA, Notkins AL (1986) Molecular mimicry. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II. Springer, New York, pp 195?202"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.81.10.3204","volume":"81","author":"JL Witzum","year":"1984","unstructured":"Witzum JL, Steinbrecher UP, Kesaniemi YA, Fisher M (1984) Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Natl Acad Sci USA 81: 3204?3208","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4612-4938-2_1","volume-title":"Diabetes and Protein Glycosylation. Measurement and Biologic Relevance","author":"MP Cohen","year":"1986","unstructured":"Cohen MP (1986) Diabetes and Protein Glycosylation. Measurement and Biologic Relevance. Springer, New York, pp 1?168"},{"key":"CR160","first-page":"45","volume-title":"Immunology in diabetes","author":"DL Rimoin","year":"1984","unstructured":"Rimoin DL, Rotter JI (1984) The genetics of diab\u00e8tes mellitus. In: Immunology in diabetes. Andreani D, DiMario U, Federlin KF, Heding LG (eds) Kimpton, London, pp 45?62"},{"key":"CR161","first-page":"115","volume":"1","author":"J Dausset","year":"1984","unstructured":"Dausset J, Hors J (1984) Immunogenetics of insulin-dependent juvenile diabetes. Diabetes Res 1: 115?123","journal-title":"Diabetes Res"},{"key":"CR162","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-3476(67)80007-6","volume":"71","author":"L Baker","year":"1967","unstructured":"Baker L, Kaye R, Root AW (1967) The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone. J Pediatr 71: 825?831","journal-title":"J Pediatr"},{"key":"CR163","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(82)92741-6","volume":"2","author":"JP Hosker","year":"1982","unstructured":"Hosker JP, Turner RC (1982) Insulin treatment of newly-presenting ketotic diabetic patients into the honeymoon period. Lancet 2: 633?635","journal-title":"Lancet"},{"key":"CR164","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bmj.1.5645.676","volume":"1","author":"K Johansen","year":"1969","unstructured":"Johansen K, Orskov H (1969) Plasma insulin during remission in juvenile diabetes mellitus. Br Med J 1: 676?678","journal-title":"Br Med J"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00274217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00274217\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00274217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:12:09Z","timestamp":1682770329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00274217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,3]]},"references-count":164,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,3]]}},"alternative-id":["BF00274217"],"URL":"https:\/\/doi.org\/10.1007\/bf00274217","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,3]]}}}